# 医院和养老院益生菌市场

> 医院和护理院益生菌市场研究报告，按益生菌配方类型（胶囊、粉末、液体、软糖、益生菌酸奶）、按目标患者群体（婴儿、成人、老年人、免疫受损患者、肠胃疾病患者）、按适应症（抗生素相关性腹泻、肠易激综合症、艰难梭菌感染、炎症性肠病、一般肠道健康）、按分销渠道（医院、护理院、药店、在线零售、医疗设施）、按产品来源（细菌菌株、酵母菌株、共生菌、发酵食品）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测至2035年。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.52%
- **2024:** $ 2.94 Billion
- **2025:** $ 3.19 Billion
- **2035:** $ 7.23 Billion
- **Key Players:** Danone (FR), Nestle (CH), Procter & Gamble (US), Kerry Group (IE), Chr. Hansen (DK), Lactalis Ingredients (FR), Synlogic (US), BioCare Copenhagen (DK), ProbioFerm (DE)

**Report ID:** MRFR/FnB/30179-HCR · **Pages:** 128 · **Author:** Varsha More · **Last Updated:** September 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/hospital-and-nursing-home-probiotic-market-31965

---

## Market Summary

## **Global Hospital and Nursing Home Probiotic Market Overview**

Hospital and Nursing Home Probiotic Market Size was estimated at 2.3 (USD Billion) in 2022.The Hospital and Nursing Home Probiotic Industry is expected to grow from 2.49(USD Billion) in 2023 to 5.2 (USD Billion) by 2032. The Hospital and Nursing Home Probiotic Market CAGR (growth rate) is expected to be around 8.5% during the forecast period (2024 - 2032).

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Key Hospital And Nursing Home Probiotic Market Trends Highlighted**

The Hospital and Nursing Home Probiotic Market is witnessing significant growth driven by the rising awareness about the benefits of probiotics in enhancing the immune system and improving gut health among patients. Increased focus on infection control in healthcare settings is pushing hospitals and nursing homes to incorporate probiotics into their treatment protocols. The aging population, who are more susceptible to infections and other health issues, is another driver, amplifying the demand for natural and preventive health solutions.

Along with this, the proliferation of clinical studies showcasing the efficacy of probiotics in managing various health conditions is further underpinning market growth.

Opportunities in the market are abundant as healthcare providers look for holistic approaches to patient care. There is potential for developing advanced probiotic formulations tailored for specific patient groups, such as those undergoing surgery or dealing with chronic diseases. The exploration of probiotic applications in mental health and other emerging areas presents a unique avenue for growth. Additionally, the increasing trend of personalized medicine could lead to a surge in demand for customized probiotic therapies catering to individual patient needs. Recent trends indicate a growing incorporation of [probiotics](../../../reports/probiotics-market-966) into everyday healthcare practices, such as preventive measures against hospital-acquired infections.

Education and training of healthcare staff about the use of probiotics will likely become more prevalent, enabling better patient adherence to probiotic therapies. Furthermore, advancements in biotechnology are paving the way for innovative probiotic products that can provide targeted health benefits. As the understanding of gut-brain interactions continues to evolve, probiotics are expected to play a key role in fostering mental and physical well-being, particularly in hospital and nursing home settings. The shift towards preventive care and overall wellness emphasizes the need for integrating probiotics as an essential component of healthcare.

## **Hospital and Nursing Home Probiotic Market Drivers**

### **Increasing Awareness of Gut Health and Microbiome**

The rise in awareness regarding the importance of gut health and its direct impact on overall well-being has significantly driven the Hospital and Nursing Home Probiotic Market Industry. As healthcare professionals and patients alike recognize the role of a balanced microbiome in disease prevention and management, the demand for probiotics within healthcare settings has surged. The healthcare community is increasingly educating patients about the benefits of probiotics in mitigating the effects of antibiotic treatments, which can disrupt the natural flora in the gut.

This proactive approach towards maintaining a healthy gut through probiotic use is particularly crucial for patients recovering from illness or surgery, where a robust immune system is vital. Moreover, probiotics are being integrated into treatment protocols, with physicians recommending specific strains tailored to individual patient needs in both hospitals and nursing homes. This trend is expected to propel the growth of the market as more healthcare institutions adopt probiotics as part of their standard care practices, aiming to improve patient outcomes and reduce healthcare costs.

In addition, ongoing research continues to uncover new applications and potential benefits of probiotics, further boosting interest in the Hospital and Nursing Home Probiotic Market Industry. The exploration of probiotics in managing chronic diseases, gastrointestinal disorders, and post-surgical recovery highlights their evolving role in modern medicine. As patients become more informed and proactive about their health, it will lead to an increase in the prescribed and consumed probiotics in healthcare settings, ultimately shaping future market dynamics.

### **Aging Population and Rising Chronic Diseases**

The increasing aging population worldwide, coupled with a rise in chronic diseases, serves as a pivotal driver for the Hospital and Nursing Home Probiotic Market Industry. As older adults often face multiple health challenges, including weakened immune systems and digestive issues, probiotics are being recognized for their potential benefits in managing these conditions. This demographic shift necessitates innovative healthcare solutions, and probiotics have emerged as a viable option to enhance health outcomes among elderly patients.

With a growing emphasis on personalized healthcare, healthcare providers are keen to incorporate probiotics into treatment regimens tailored to the unique needs of older individuals, increasing their overall acceptability within hospital and nursing home settings.

### **Advancements in Probiotic Research and Product Development**

Continued advancements in probiotic research and the development of new products are significantly influencing the growth of the Hospital and Nursing Home Probiotic Market Industry. Researchers are exploring various strains of probiotics and their specific health benefits, leading to a broader range of effective options available to healthcare providers. Furthermore, innovations in delivery methods and formulations are enhancing the practical application of probiotics in clinical settings, paving the way for more positive outcomes.

As the availability of high-quality, effective probiotic products increases, healthcare facilities are more likely to adopt these solutions, contributing to the market's expansion.

## **Hospital and Nursing Home Probiotic Market Segment Insights**

### **Hospital and Nursing Home Probiotic Market Probiotic Formulation Type Insights**

The Hospital and Nursing Home Probiotic Market focuses significantly on the Probiotic Formulation Type segment, showcasing a diverse range of formulations that cater to various patient needs. In 2023, the market is valued at 2.49 USD Billion and is projected to reach 5.2 USD Billion by 2032, representing strong growth potential. The Probiotic Formulation Type encompasses five primary categories, namely Capsules, Powder, Liquid, Soft Chew, and Probiotic Yogurt, each contributing variably to the overall market landscape.

Among these, the Capsules formulation dominates, valued at 0.85 USD Billion in 2023 and anticipated to grow to 1.8 USD Billion by 2032, indicating its popularity due to ease of consumption and convenience for patients, particularly those in a hospital or nursing home setting.

The Powder formulation follows closely, holding a value of 0.65 USD Billion in 2023 and expected to reach 1.4 USD Billion by 2032, signifying its application in a variety of therapeutic solutions, particularly in the pediatric and senior care sectors where it can be easily incorporated into food and drinks. The Liquid formulation also plays a crucial role, starting at 0.55 USD Billion in 2023 and projected to rise to 1.2 USD Billion by 2032, appealing to patients who prefer or require liquid intake methods for easier digestion.

On the other hand, Soft Chew products are valued at 0.25 USD Billion in 2023, with prospects to reach 0.5 USD Billion by 2032, catering to a unique demographic that values palatability and ease of intake, often favored in geriatric care.

Lastly, Probiotic Yogurt stands at a value of 0.19 USD Billion in 2023, increasing to 0.3 USD Billion by 2032; while it represents a smaller market share, it offers an enjoyable means for patients to incorporate probiotics into their diet, thus fostering better adherence to probiotic intake recommendations. Each formulation type serves distinct patient preferences and dietary needs within hospitals and nursing homes, influencing the Hospital and Nursing Home Probiotic Market revenue and illustrating the importance of tailored therapeutic solutions.

The market trends depict a growing recognition of probiotics' health benefits, and as healthcare professionals increasingly endorse these formulations, it paves the way for new product developments and marketing strategies aimed at enhancing patient compliance and overall health outcomes.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Hospital and Nursing Home Probiotic Market Target Patient Group Insights**

The Hospital and Nursing Home Probiotic Market, valued at 2.49 USD Billion in 2023, has shown notable segmentation focused on various target patient groups. Each group plays a pivotal role in driving market development, with a focus on Infants and Elderly populations, who often face unique health challenges that probiotics can address, such as enhancing gut health and boosting immunity. Notably, the Adults segment also exhibits substantial demand, attributed to an increasing trend toward preventive healthcare. Immunocompromised Patients depend heavily on probiotics for maintaining gut balance and overall health, highlighting their critical importance in clinical settings.

Patients with Gastrointestinal Disorders represent a significant portion of the market, as these individuals often seek probiotics to alleviate symptoms and promote healing. The Hospital and Nursing Home Probiotic Market statistics suggest that the market will continue to evolve, driven by factors like an aging population and rising health awareness. While opportunities for growth remain prevalent, challenges such as regulatory scrutiny and the need for robust clinical evidence are present in the industry landscape. Overall, the ample potential within the target patient groups indicates a favorable outlook for the continued expansion of probiotic applications in healthcare settings.

### **Hospital and Nursing Home Probiotic Market Indication Insights**

In 2023, the Hospital and Nursing Home Probiotic Market was valued at 2.49 USD Billion, demonstrating a growing recognition of probiotics' importance in clinical settings. The Indication segment showcases diverse areas, such as Antibiotic-Associated Diarrhea, where the demand for probiotics is significant due to the common occurrence of treatment-related digestive issues. Irritable Bowel Syndrome is another critical area where probiotics have shown promising effects, leading to increased patient interest and usage. Clostridium difficile Infection, known for posing severe health risks, has heightened the focus on therapeutic probiotics as preventive and supportive measures.

Inflammatory Bowel Disease contributes to the rising need for specialized probiotic formulations, catering to affected patients seeking relief. General Gut Health also drives market demand, as individuals and healthcare providers are increasingly aware of the benefits probiotics provide beyond specific conditions. The overall growth is fueled by factors like the increasing prevalence of gastrointestinal disorders, the growing aging population, and rising awareness of maintaining gut health, highlighting the necessity of exploring various indications within the Hospital and Nursing Home Probiotic Market.

### **Hospital and Nursing Home Probiotic Market Distribution Channel Insights**

The Hospital and Nursing Home Probiotic Market revenue is witnessing substantial growth, with a valuation of 2.49 USD Billion in 2023. This growth can be largely attributed to the diverse distribution channels that play a pivotal role in market expansion. Among these channels, Hospitals and Nursing Homes are significant contributors, as they serve as primary nodes for probiotic administration and are critical for patient care. Pharmacies also characterize a vital segment, providing convenient access to probiotic products for consumers seeking health benefits.

Online retail is emerging as a dominant distribution channel due to the rising trend of e-commerce, emphasizing consumer preference for purchasing health products from the comfort of their homes. Additionally, Healthcare Facilities facilitate the direct supply of probiotics, enabling professional recommendations that bolster consumer trust. The increasing awareness of probiotics' health benefits, coupled with a growing geriatric population, supports the overall growth of this sector. However, challenges such as regulatory hurdles and competition from traditional medications persist.

Nonetheless, opportunities for innovation in product delivery and consumer education continue to shape the landscape of the Hospital and Nursing Home Probiotic Market industry.

### **Hospital and Nursing Home Probiotic Market Product Source Insights**

The Hospital and Nursing Home Probiotic Market is currently valued at 2.49 billion USD in 2023 and is poised for significant expansion. Within the Product Source segment, major categories include Bacterial Strains, Yeast Strains, Synbiotics, and Fermented Foods. Bacterial Strains hold a majority share in market revenue due to their extensive application in healthcare settings, as they effectively address various gastrointestinal issues and promote overall well-being. Yeast Strains are also important, as they contribute to enhancing patients' immune responses and gut health.

Additionally, Synbiotics, which combine prebiotics and probiotics, are gaining traction for their ability to synergistically improve health outcomes. Lastly, Fermented Foods appeal to a growing consumer preference for natural and functional food options. The market growth in this segment is driven by increasing awareness of probiotic benefits and rising demand in hospitals and nursing homes for effective solutions to improve patient health and recovery. The insights reflect a trend towards more personalized and holistic approaches in healthcare settings, further influencing overall market dynamics.

**Hospital and Nursing Home Probiotic Market Regional Insights**

The Hospital and Nursing Home Probiotic Market is experiencing significant growth across various regions, with a total valuation reaching 2.49 USD Billion in 2023 and projected to expand further. North America holds a significant position in this market, valued at 0.99 USD Billion in 2023, reflecting its majority holding due to advanced healthcare systems and increasing awareness of probiotics in hospitals. Europe follows closely with a valuation of 0.79 USD Billion, driven by strong regulatory support and growing adoption of probiotics in nursing homes.

Meanwhile, Asia Pacific represents a promising market with a valuation of 0.62 USD Billion in 2023, attributed to a rising aging population and increased healthcare expenditures. The Middle East and Africa region shows minimal value at 0.05 USD Billion, indicating a nascent stage in market development, while South America, valued at 0.05 USD Billion, presents opportunities for growth but faces challenges due to limited healthcare infrastructures. Each of these regional insights underscores the dynamic landscape of the Hospital and Nursing Home Probiotic Market and highlights potential areas for investment and expansion.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Hospital And Nursing Home Probiotic Market Key Players And Competitive Insights**

The Hospital and Nursing Home Probiotic Market is characterized by a dynamic landscape, where numerous players compete to establish their presence in this niche yet growing sector. As healthcare facilities increasingly recognize the importance of probiotics in enhancing patient outcomes, the market has witnessed a surge in interest and investment. Probiotics are known for their significant role in supporting gut health, which is particularly crucial in hospital and nursing home settings, where patients often experience compromised immune systems.

The competitive landscape is influenced by factors such as innovation in probiotic formulations, strategic partnerships, and a focus on delivering evidence-based products to healthcare providers. Companies are striving to differentiate themselves through high-quality, efficacious probiotic strains that meet the specific needs of patients in sensitive environments.

Kerry Group has positioned itself robustly within the Hospital and Nursing Home Probiotic Market through a sustained commitment to research and product development. The company focuses on leveraging its extensive expertise in the food and nutrition sectors to develop tailored probiotic solutions that cater to the unique dietary requirements of patients in healthcare settings. With a strong emphasis on quality and efficacy, Kerry Group has developed a range of probiotic offerings that are not only functional but also compatible with specific dietary needs such as lactose intolerance or low-sugar requirements.

The company’s advanced manufacturing capabilities and dedication to safety ensure that their probiotic products can be trusted by healthcare professionals in the hospital and nursing home context. Furthermore, Kerry Group's collaboration with research institutions reinforces its reputation as a leader in the development of scientifically-backed probiotic solutions.

Chr. Hansen is another prominent player in the Hospital and Nursing Home Probiotic Market, known for its commitment to innovation and sustainability. The company specializes in developing high-quality probiotics with proven benefits for gut health, immunity, and overall wellness. Chr. Hansen's strong emphasis on research and development allows it to stay at the forefront of probiotic science, continually advancing its product offerings to meet the evolving needs of healthcare providers. Their products are extensively tested for efficacy and safety, making them highly regarded among healthcare professionals. Chr.

Hansen also prioritizes strong customer relationships, ensuring that its probiotic solutions are designed with input from healthcare practitioners. This collaborative approach not only strengthens their product acceptance in hospitals and nursing homes but also reinforces Chr. Hansen’s position as a trusted partner in healthcare innovation. Through their sustainability initiatives, the company aligns itself with modern healthcare values, which is increasingly important for institutions aiming to improve patient care while also being environmentally responsible.

### **Key Companies in the Hospital and Nursing Home Probiotic Market Include**

**Hospital and Nursing Home Probiotic Market Industry Developments**

Recent developments in the Hospital and Nursing Home Probiotic Market indicate a notable increase in demand for probiotic supplements in healthcare settings, driven by an increased focus on gut health and infection prevention. Companies like Synlogic and DuPont have been actively launching new probiotic formulations tailored for clinical applications, catering to the growing interest from healthcare providers. Current affairs highlight the ongoing collaboration between biotech firms and hospitals to study the efficacy of probiotics in improving patient outcomes, particularly concerning antibiotic-associated complications.

Additionally, significant mergers and acquisitions have been observed, such as the acquisition of ProbioFerm by the health and wellness company Bifodan, which bolsters their product offerings and market position. The valuation of companies within the sector, including Thrive Probiotic and BioCare Copenhagen, is witnessing substantial growth, which is projected to contribute positively to the overall market growth. This investment influx is enhancing research capabilities and product development, thereby expanding the market's potential to meet increasing healthcare demands.

## **Hospital And Nursing Home Probiotic Market Segmentation Insights**

### **Hospital and Nursing Home Probiotic Market Probiotic Formulation Type Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Target Patient Group Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Indication Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Distribution Channel Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Product Source Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Regional Outlook**

- - North America - Europe - South America - Asia Pacific

## Market Drivers

### Growing Focus on Preventive Healthcare

向预防性医疗保健的转变正在影响[医院和疗养院益生菌](https://www.marketresearchfuture.com/reports/hospital-and-nursing-home-probiotic-market-31965)市场。随着世界各地的医疗保健系统强调预防胜于治疗，益生菌因其在维持肠道健康和预防感染方面的作用而受到认可。数据表明，益生菌可以减少抗生素相关性腹泻的发生率，这是医院环境中常见的问题。这种预防方法不仅加强了患者护理，而且符合减少再入院的更广泛的医疗保健趋势。因此，医院和疗养院越来越多地采用益生菌干预措施作为其预防策略的一部分，这可能会导致市场需求持续增长。

### Regulatory Support for Probiotic Products

监管机构越来越认识到益生菌的好处，这对医院和疗养院益生菌市场产生了积极影响。最近益生菌配方的指南和批准鼓励医疗保健提供者将这些产品纳入他们的治疗方案中。这种监管支持不仅提高了益生菌的可信度，而且有利于其融入临床实践。随着医院和疗养院寻求基于证据的解决方案来改善患者护理，经过临床验证的益生菌产品的可用性可能会推动市场扩张。此外，持续的研究和开发工作可能会带来新的益生菌菌株的引入，进一步丰富市场格局。

### Increasing Incidence of Digestive Disorders

肠易激综合症和炎症性肠病等消化系统疾病的患病率不断上升，似乎是医院和疗养院益生菌市场的重要驱动力。根据最新数据，近 15% 的人口存在某种形式的消化问题，导致对益生菌解决方案的需求增加。医院和疗养院越来越多地将益生菌纳入其治疗方案中，以增强肠道健康并改善患者的治疗效果。随着医疗保健提供者认识到益生菌在管理消化系统疾病方面的潜在益处，这种趋势可能会持续下去。此外，将益生菌融入临床环境可能会提高患者满意度并降低医疗成本，从而加强市场的增长轨迹。

### Aging Population and Increased Healthcare Needs

人口老龄化是推动医院和疗养院益生菌市场的关键因素。随着年龄的增长，他们的肠道健康状况往往会下降，使他们更容易受到感染和消化系统疾病的影响。益生菌已被证明可以支持免疫功能并改善肠道微生物群平衡，这对老年患者特别有益。据预测，到 2050 年，全球 65 岁及以上人口将达到 15 亿，医疗保健机构对益生菌的需求预计将增加。医院和疗养院可能会扩大益生菌产品以满足这一人群的需求，从而推动市场增长。

### Rising Demand for Functional Foods and Supplements

消费者对功能性食品的兴趣日益浓厚[膳食补充剂](https://www.marketresearchfuture.com/reports/dietary-supplements-market-1134)正在影响医院和疗养院益生菌市场。患者和医疗保健提供者越来越意识到益生菌对健康的益处，导致对富含益生菌的食品和补充剂的需求激增。这种趋势在医院和疗养院环境中尤其明显，因为营养在患者康复中发挥着至关重要的作用。益生菌正在被纳入膳食计划和饮食建议中，反映出向整体健康方法的更广泛转变。随着功能性食品市场的持续增长，医院和疗养院可能会扩大其益生菌产品，从而促进整体市场的增长。

## Future Outlook

医院和护理院益生菌市场预计将在2024年至2035年间以8.52%的年均增长率增长，推动因素包括对肠道健康的认识提高和医疗支出增加。

**New opportunities:**

- 为特定患者群体开发定制的益生菌配方。

到2035年，市场预计将强劲，反映出显著的增长和创新。

## Segment Insights

### 按益生菌配方类型：胶囊（最大）与粉末（增长最快）

医院和疗养院益生菌市场呈现出多样化的配方类型，其中胶囊占据了最大的市场份额。这种形式因其方便和易于消费而受到高度青睐，特别是对于可能难以适应更复杂形式的老年患者。继胶囊之后，粉剂获得了显着的关注，特别是在需要可定制剂量和灵活性的环境中。液体形式和益生菌酸奶也有助于市场动态，吸引不同的患者偏好和饮食需求。最近的趋势表明粉末配方发生了重大转变，粉末配方正在成为增长最快的部分。将这些益生菌融入冰沙和其他食品中的能力使其对旨在改善患者营养的医院和疗养院特别有吸引力。此外，人们对肠道健康的认识不断增强，推动了对创新形式的需求，进一步增强了所有配方类型的增长潜力。

胶囊（主导）与粉末（新兴）

胶囊是医院和疗养院益生菌市场中益生菌的主要形式，主要是因为它们易于储存且剂量准确。这种形式最大限度地降低了污染风险，并具有较长的保质期，这对于医疗保健环境至关重要。相比之下，粉末益生菌因其多功能性而迅速成为护理人员的首选。将粉末混合到食物或饮料中的能力使其对于吞咽药片有困难的患者来说非常实用。此外，粉末形式支持更大程度的定制，使医疗保健专业人员能够根据个人健康需求定制益生菌的摄入量，从而推动其市场渗透。

### 按目标患者群体：婴儿（最大）与老年人（增长最快）

在医院和疗养院益生菌市场中，婴儿细分市场价值占据突出地位，由于人们越来越意识到益生菌对早期发育的好处，因此反映了最高的市场份额。这一人群特别受到关注婴儿肠道健康的医疗保健提供者和父母的关注，从而导致了稳定的需求。相反，在胃肠道疾病患病率不断上升以及老龄化人口健康管理意识增强的推动下，老年人群体正在迅速崛起。该群体在寻求增强消化健康和整体健康的解决方案时，益生菌的消费量显着增加，这表明市场焦点已转向老年消费者。

婴儿：主导型 vs. 老年人：新兴型

婴儿细分市场的特点是非常重视开发专门满足新生儿和幼儿需求的解决方案。这一人群需要高质量、安全且有效的益生菌产品，以从小就促进健康的肠道菌群并支持免疫功能。相比之下，老年人群越来越倾向于益生菌，以解决通常与衰老相关的消化健康问题，例如便秘和肠道菌群失调。两个细分市场都呈现出不同的市场特征；婴儿以既定的需求为主导，而老年消费者则代表着一个新兴市场，其健康意识不断提高，创新的益生菌配方满足了他们独特的健康挑战。

### 按适应症：艰难梭菌感染（最大）与肠易激综合症（增长最快）

在医院和疗养院益生菌市场，适应症细分市场的特点是对益生菌的反应不同。艰难梭菌感染占据了最大的市场份额，这主要是由于抗生素相关的肠道健康破坏发生率不断上升。随后，由于寻求缓解胃肠道疾病的患者的认识和诊断率不断提高，肠易激综合症作为增长最快的部分受到关注。

艰难梭菌感染（显性）与肠易激综合征（新发）

艰难梭菌感染领域至关重要，其特点是住院患者反复感染，给医疗机构带来巨大负担。针对这一适应症的益生菌用于恢复肠道微生物群，显着降低复发率。相比之下，肠易激综合症部分正在兴起，其特点是它吸引了越来越多寻求预防性健康措施的人群。随着医疗保健提供者强调肠道健康管理，并得到将益生菌与症状缓解联系起来的研究的支持，这一细分市场正在迅速普及，并将其定位为益生菌制剂未来发展的关键焦点。

### 按分销渠道：医院（最大）与在线零售（增长最快）

在医院和疗养院益生菌市场中，分销渠道在市场渗透和产品可用性方面发挥着关键作用。医院占据了最大的市场份额，这主要是因为它们有能力将益生菌纳入患者护理方案，并且人们越来越认识到这些产品的健康益处。另一方面，疗养院和药店等渠道也对分销格局做出了重大贡献，但在整体市场份额方面落后于医院。

医疗设施：医院（主要）与疗养院（新兴）

医院仍然是医疗机构内益生菌分配的主导力量。它们为益生菌的管理提供了一个结构化的环境，确保满足特定患者的需求。相比之下，疗养院代表了一个新兴领域，它们越来越认识到益生菌对老年居民整体福祉和免疫健康的重要性。虽然医院受益于既定的协议和更大的网络，但疗养院正在经历对益生菌益处的认识提高所推动的增长，调整他们的护理模式以整合这些产品以获得更好的健康结果。

### 按产品来源：细菌菌株（最大）与合生元（增长最快）

在医院和疗养院益生菌市场中，细菌菌株由于其既定的功效和在各种治疗应用中的广泛使用而占据最大份额。具体来说，乳杆菌和双歧杆菌等菌株在这一类别中占主导地位，极大地提高了消费者对医院和护理机构的偏好。与此同时，酵母菌株和发酵食品领域紧随其后，但它们占据的市场份额较小，主要是因为其独特的益生菌功效。总体而言，细菌菌株引领市场，反映出人们对其在临床环境中的表现的长期信任。

细菌菌株（优势）与合生元（新兴）

细菌菌株仍然是医院和疗养院益生菌市场的主导力量，因其强大的健康益处而受到认可，包括增强肠道健康和增强免疫系统。医院环境中使用的常见菌株，例如乳酸菌和双歧杆菌，其治疗优势已得到充分记录，使医疗保健提供者可以识别它们。另一方面，随着医疗保健专业人员寻求患者健康管理的全面解决方案，将益生元和益生菌结合在一起的合生元正在迅速兴起。它们支持肠道微生物群和整体健康的能力使它们成为一个有吸引力的选择，满足老龄化人群对创新益生菌应用不断增长的需求。

## Regional Market Share Analysis

### 北美：益生菌市场领导者

北美是医院和疗养院益生菌的最大市场，约占全球份额的45%。这一增长是由人们对肠道健康意识的增强、医疗保健支出的增加和支持性监管框架推动的。人口老龄化和慢性病的流行进一步推动了医疗保健环境中对益生菌的需求，这需要先进的营养解决方案。美国领先北美市场，其次是加拿大。宝洁和达能等主要参与者正在积极投资于研发，以创新益生菌配方。竞争格局的特点是战略合作伙伴关系和收购，增强产品供应和市场覆盖范围。知名品牌的存在确保了强大的供应链和消费者的信任，进一步巩固了北美在益生菌市场的地位。

### 欧洲：有法规的新兴市场

欧洲的医院和疗养院益生菌市场正在显着增长，约占全球份额的 30%。需求的增长归因于健康意识的增强、老年人口的增加以及促进益生菌在医疗保健中使用的严格法规。欧洲食品安全局 (EFSA) 在制定确保产品安全和功效的指导方针方面发挥了重要作用，从而增强了消费者的信心。该地区的主要国家包括德国、法国和英国，其中德国是最大的市场。达能 (Danone) 和科汉 (Chr.) 等主要参与者科汉森专注于为医疗保健环境量身定制的创新益生菌解决方案。竞争格局的特点是医疗保健提供者和益生菌制造商之间的合作，提高了产品的可及性和认知度。这种协同作用对于推动市场增长和满足医疗机构不断变化的需求至关重要。

### 亚太地区：快速扩张的市场

亚太地区正在迅速崛起，成为医院和疗养院益生菌市场的重要参与者，占据全球约 20% 的份额。这一增长的推动因素包括医疗保健投资的增加、肠道健康意识的提高以及老年人口的增加。在政府促进医疗保健环境健康的举措的支持下，中国和印度等国家对益生菌的需求正在激增。中国是该地区最大的市场，其次是日本和印度。竞争格局既有本地企业，也有国际企业，其中雀巢和凯爱瑞集团等公司处于领先地位。该市场的特点是益生菌产品种类繁多，专为满足医疗机构的特定需求而定制。这种充满活力的环境促进创新，提高医院和疗养院益生菌的供应，满足对有效健康解决方案不断增长的需求。

### 中东和非洲：医疗保健领域的新兴机遇

中东和非洲地区在医院和疗养院益生菌市场逐渐崛起，约占全球份额的5%。这一增长的推动因素包括医疗保健投资的增加、肠道健康意识的提高以及老年人口的增加。各国政府开始认识到益生菌在医疗保健中的重要性，从而出台了鼓励医院和疗养院使用益生菌的支持政策。南非和阿联酋等国家处于这一增长的前沿，医疗保健环境中对益生菌产品的需求不断增加。随着本地和国际参与者进入市场，竞争格局正在不断变化。公司正致力于向医疗保健专业人员宣传益生菌的好处，这对于推动医院和疗养院的采用至关重要。这个新兴市场为益生菌领域的增长和创新提供了巨大的机遇。

## Competitive Benchmarking

医院和疗养院益生菌市场的特点是充满活力，众多参与者竞相在这个利基但不断增长的领域建立自己的地位。随着医疗机构越来越认识到益生菌在改善患者治疗效果方面的重要性，市场的兴趣和投资激增。益生菌以其在支持肠道健康方面的重要作用而闻名，这在医院和疗养院环境中尤其重要，因为患者的免疫系统经常受到损害。竞争格局受到益生菌配方创新、战略合作伙伴关系以及注重向医疗保健提供者提供循证产品等因素的影响。公司正在努力通过高质量、有效的益生菌菌株来满足敏感环境中患者的特定需求，从而使自己脱颖而出。凯爱瑞集团通过持续致力于研究和产品开发，在医院和疗养院益生菌市场中占据了稳固的地位。该公司专注于利用其在食品和营养领域的广泛专业知识来开发定制的益生菌解决方案，以满足医疗保健环境中患者的独特饮食需求。嘉里集团高度重视质量和功效，开发了一系列益生菌产品，这些产品不仅具有功能性，而且能够满足特定的饮食需求，例如乳糖不耐受或低糖要求。该公司先进的制造能力和对安全的奉献精神确保其益生菌产品能够受到医院和疗养院医疗保健专业人员的信赖。此外，嘉里集团与研究机构的合作巩固了其作为开发有科学支持的益生菌解决方案领导者的声誉。科。科汉森是医院和疗养院益生菌市场的另一家知名企业，以其对创新和可持续发展的承诺而闻名。该公司专注于开发高品质益生菌，这些益生菌已被证明对肠道健康、免疫力和整体健康有益。科。科汉森对研发的高度重视使其始终处于益生菌科学的前沿，不断改进其产品以满足医疗保健提供者不断变化的需求。他们的产品经过广泛的功效和安全性测试，在医疗保健专业人士中备受推崇。科。科汉森还优先考虑牢固的客户关系，确保其益生菌解决方案的设计考虑了医疗保健从业者的意见。这种合作方式不仅提高了医院和疗养院对产品的接受度，还增强了科汉姆的实力。科汉森作为医疗保健创新领域值得信赖的合作伙伴的地位。通过可持续发展举措，该公司与现代医疗保健价值观保持一致，这对于旨在改善患者护理同时对环境负责的机构来说越来越重要。

## Recent News & Developments

医院和疗养院益生菌市场的最新发展表明，由于对肠道健康和感染预防的日益关注，医疗机构对益生菌补充剂的需求显着增加。 Synlogic 和杜邦等公司一直在积极推出专为临床应用量身定制的新益生菌配方，以满足医疗保健提供者日益增长的兴趣。时事报道强调了生物技术公司和医院之间正在进行的合作，以研究益生菌在改善患者预后方面的功效，特别是在抗生素相关并发症方面。

此外，还发生了重大并购，例如健康和保健公司 Bifodan 收购了 ProbioFerm，这增强了他们的产品供应和市场地位。该行业内公司（包括 Thrive Probiotic 和 BioCare Copenhagen）的估值正在大幅增长，预计将对整体市场增长做出积极贡献。这些投资的涌入正在增强研究能力和产品开发，从而扩大市场潜力，以满足日益增长的医疗保健需求。

## Report Scope

| 2024 年市场规模 | 2.939(USD Billion) |
| --- | --- |
| 2025 年市场规模 | 3.19(USD Billion) |
| 2035 年市场规模 | 7.226(USD Billion) |
| 复合年增长率 (CAGR) | 8.52% (2025 - 2035) |
| 报告范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 史料 | 2019 - 2024 |
| 市场预测单位 | USD Billion |
| 主要公司简介 | 达能（法国）、雀巢（瑞士）、宝洁公司（美国）、凯里集团（爱尔兰）、科瑞集团（Chr.） Hansen (丹麦)、Lactalis Ingredients (法国)、Synlogic (美国)、BioCare Copenhagen (丹麦)、ProbioFerm (德国) |
| 涵盖的细分市场 | 益生菌配方类型、目标患者群体、适应症、分销渠道、产品来源、区域 |
| 主要市场机会 | 整合先进的益生菌配方，以促进医疗机构中的患者康复和肠道健康。 |
| 主要市场动态 | 医疗保健环境中对益生菌的需求不断增长，推动了医院和疗养院益生菌市场的创新和监管审查。 |
| 覆盖国家 | 北美、欧洲、亚太地区、南美洲、MEA |

## Frequently Asked Questions

**Q: 到2035年，医院和护理院益生菌市场的预计市场估值是多少？**
A: 预计到2035年，医院和护理院益生菌市场的市场估值为72.26亿美元。

**Q: 2024年医院和护理院益生菌市场的市场估值是多少？**
A: 2024年医院和护理院益生菌市场的整体市场估值为29.39亿美元。

**Q: 2025年至2035年，医院和护理院益生菌市场的预期CAGR是多少？**
A: 医院和护理院益生菌市场在2025年至2035年预测期内的预期CAGR为8.52%。

**Q: 在医院和护理院益生菌市场中，哪些公司被视为关键参与者？**
A: 市场的主要参与者包括达能、雀巢、宝洁、凯利集团、克里斯·汉森、拉克塔利斯成分、Synlogic、BioCare Copenhagen 和 ProbioFerm。

**Q: 2025年益生菌胶囊的预计收入是多少？**
A: 预计益生菌胶囊将在2025年产生19.78亿美元的收入。

**Q: 2025年，益生菌粉的收入与益生菌液体的收入相比如何？**
A: 到2025年，益生菌粉预计将产生13.68亿美元的收入，这与益生菌液体的预计收入相等。

**Q: 2025年针对老年患者的益生菌预期收入是多少？**
A: 针对老年患者的益生菌预计将在2025年产生15亿美元的收入。

**Q: 预计哪个分销渠道在2025年将产生最高收入？**
A: 预计到2025年，医院将产生最高的收入，预计为19.78亿美元。

**Q: 2025年益生菌酸奶的预期收入是多少？**
A: 预计益生菌酸奶将在2025年产生12.26亿美元的收入。

**Q: 2025年针对胃肠道疾病患者的益生菌产品预计收入是多少？**
A: 针对胃肠道疾病患者的益生菌产品预计将在2025年产生15.26亿美元的收入。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/hospital-and-nursing-home-probiotic-market-31965*